{"nct_id":"NCT04809467","title":"A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2021-09-16","start_date_type":"ACTUAL","primary_completion_date":"2024-10-22","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-22","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}